AmerisourceBergen, a healthcare solutions company, recently launched a dedicated corporate venture capital fund with $150 million allocated for investment in early-to mid-stage health-related startups.
The fund, AB Health Ventures, will invest in and partner with emerging healthcare startup companies worldwide that are working to transform healthcare for people and animals. The fund will prioritize investments in entrepreneurs who are pursuing bold ideas in areas such as the future of pharmacy and distribution, clinical development and commercialization of pharmaceuticals, practice solutions for healthcare providers, and animal health.
The investment will help the startups with such things as prototype solutions, testing with pilots, and accelerating scale through commercialization.
“I believe that innovation is the catalyst to sustained progress and change, which is why AmerisourceBergen is committed to taking bold, innovative actions to achieve our purpose and drive long-term growth,” Steve Collis, AmerisourceBergen chairman, president and CEO, said. “The creation of AB Health Ventures will build on our track record of success as we identify meaningful partnerships that will bring emerging healthcare solutions to market and create healthier futures for all.”
AB Health Ventures is a wholly-owned subsidiary of AmerisourceBergen. Touchdown Ventures, a firm specializing in corporate venture capital, will help manage the AB Health Ventures fund.